Concepedia

Xiao Ding

XD

Statistics

Publications

21

Citations

700

H-Index

13

Active since

2015

Affiliations

Roche (China)(Current)

Chinese Academy of Sciences

Shanghai University

Shanghai Institute of Organic Chemistry

Hong Kong Science and Technology Parks Corporation

Xiao Ding is an author at Roche (China) specializing in drug design, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2015–2025

21

Publications

21

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 326 citations · Full text

, , +8

Discovery of Pyrido[2,3-<i>b</i>]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV

Yimin Hu, Houguang Shi, Mingwei Zhou et al. · Journal of Medicinal Chemistry · 2020 · 71 citations

, , +17

A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro

Jing Sun, Deheng Sun, Qi Yang et al. · Nature Communications · 2025 · 27 citations · Full text

, , +15

Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer

Yangguang Li, Yingtao Liu, Jianping Wu et al. · Journal of Medicinal Chemistry · 2023 · 25 citations · Full text

, , +13

Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer

Yazhou Wang, Chao Wang, Tingting Liu et al. · Journal of Medicinal Chemistry · 2023 · 25 citations · Full text

, , +14

1–5 of 21